Are hemoglobin A (HbA) and hemoglobin S (HbS) both elevated in patients with sickle cell disease, particularly those with the HbSS genotype?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 20, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hemoglobin Patterns in Sickle Cell Disease

No, hemoglobin A (HbA) and hemoglobin S (HbS) are NOT both elevated in classic sickle cell disease (HbSS genotype)—patients with HbSS have predominantly or exclusively HbS with little to no HbA present. 1, 2

Hemoglobin Electrophoresis Patterns by Genotype

The hemoglobin composition varies dramatically depending on the specific sickle cell genotype:

HbSS (Sickle Cell Anemia - Most Severe Form)

  • HbS comprises 80-100% of total hemoglobin 1, 3
  • HbA is absent or nearly absent (0-10%) 1
  • HbF levels are typically less than 1-3% 1
  • This represents the classic and most severe form of sickle cell disease 4

Sickle Cell Trait (HbAS - Carrier State)

  • HbA levels are 55-65% 1
  • HbS levels are 30-40% 1
  • This is a benign carrier state, not sickle cell disease 1

Sickle Beta-Plus Thalassemia (HbS/β+ Thal)

  • HbS levels are 70-80% 1
  • HbA levels are reduced to 10-25% 1
  • HbA2 is elevated above 3-5% 1
  • This represents a mild-to-moderate clinical phenotype of actual sickle cell disease requiring disease-specific management 1

Sickle Beta-Zero Thalassemia (HbS/β⁰ Thal)

  • No HbA is present 1
  • HbS levels are 80-90% 1
  • HbF levels are 5-15% 1
  • This creates a severe clinical phenotype resembling HbSS disease 1

Critical Clinical Distinction

The presence or absence of HbA is the key distinguishing feature between different sickle cell genotypes and determines disease severity. 1, 4

  • Patients with HbSS have essentially no functional HbA production due to homozygous inheritance of the sickle mutation 2, 3
  • The pathophysiology stems from HbS polymerization at low oxygen tension, causing red cell rigidity and vaso-occlusion 5, 6
  • Baseline hemoglobin levels in severe sickle cell disease are chronically low at 60-90 g/L (6-9 g/dL), which represents their steady state 7, 5

Common Pitfall to Avoid

Do not confuse sickle cell trait (carrier state with both HbA and HbS present) with sickle cell disease (HbSS genotype with predominantly HbS). 1 Only the trait has substantial amounts of both hemoglobins; the disease state has predominantly or exclusively HbS.

References

Guideline

Hemoglobin Electrophoresis in Sickle Cell Trait with Thalassemia Compound Heterozygotes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Sickle Cell Disease.

Annals of internal medicine, 2021

Guideline

Diagnostic Indicators of Sickle Cell Crisis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.